Shringar House of Mangalsutra IPO: A Golden Opportunity or Just Another Sparkle?

Explore the Shringar House of Mangalsutra IPO 2025 get all the key dates, category-wise lot sizes, ROE, ROCE, debt-equity, P/E ratios, pros, cons and final verdict before you subscribe.

---

About the Company

Founded in 2009, Shringar House of Mangalsutra Ltd. specializes in designing and manufacturing Mangalsutras using 18k and 22k gold, adorned with American diamonds, pearls and semi-precious stones. Their clientele includes big names like Titan, Malabar Gold, Reliance Retail and even international players like Damas Jewellery (UAE). As of FY24, they’ve served:

• 33 corporate clients
• 96 wholesalers
• 832 retailers

Shringar House of Mangalsutra have also expanded globally, selling in the UK, USA, UAE, New Zealand, and Fiji

---

Important IPO Dates

Event	Date
Anchor Investor Subscription	September 9, 2025
IPO Opens	September 10, 2025
IPO Closes	September 12, 2025
Allotment Finalized	September 15, 2025
Expected Listing Date	September 17, 2025

---

Lot Size & Bidding Details

The Shringar House of Mangalsutra IPO is spread across investor categories with a minimum lot size of 90 shares, pitched at ₹155–₹165 per share. Here’s how it breaks down:

Investor Category	Lots	Shares	Investment (₹)
Retail Investor	1 lot	90	₹14,850
Small HNI (sNII)	14 lots	1,260	₹2,07,900
Big HNI (bNII)	68 lots	6,120	₹10,09,800

---

Key Financial Indicators

Indicator	FY 2025 Pre‑IPO
Return on Net Worth (RoNW)	36.20%
Return on Capital Employed (RoCE)	32.43%
Debt-to-Equity Ratio	0.61
Price to Book (P/B)	NAV = ₹27.84
PE Ratio (Pre IPO)	18.09–19.25×
PE Ratio (Post IPO)	24.45–26.03×

Financial Performance

Metric	FY2023	FY2024	FY2025
Revenue (₹ crores)	950.2	1,101.5	1,429.8
PAT (₹ crores)	23.4	31.1	61.1

---

Use of IPO Proceeds

₹280 crore for working capital

Remaining funds for general corporate purposes

---

Pros, Cons & Final Thoughts

Pros

• Fast-Growing Financials: Revenue up nearly 30% and profit almost doubled in FY25.
• Strong Returns and Good Leverage: RoNW over 36%, RoCE above 32%, and debt ratio below 1 suggesting efficient operations.
• Valuable Client Base: B2B relationships with big names like Titan, Malabar Gold, Reliance Retail, Joyalukkas and others.
• Unique Niche Specialist: Focus solely on mangalsutras only organized player with ~6% market share.
• Clear Capital Use: Funds are earmarked for working capital, potentially fueling further growth

Cons

• Single-Product Focus: Heavy reliance on mangalsutra demand, limited diversification.
• Underutilized Manufacturing Capacity: Utilization rates hover around 66–70% with potential risk if demand doesn’t rise.
• Seasonal Demand Volatility: Jewelry purchases peak during festivals, leading to seasonal revenue dips.
• Geographic Concentration: Operations centered in Mumbai, exposure to regional or localized disruptions.
• Valuation Pressure: GMP indicates expected listing gain, but aggressive valuations could curb long-term returns. Latest GMP at ₹20 suggests ~12% listing gain, or up to ₹190 listing price (~15% higher than ₹165

Final Thoughts

If you’re looking for a well-scripted SME IPO with solid financials, trusted client relationships and potential upside from a focused niche, Shringar House of Mangalsutra is a compelling candidate.

However, due to its single-product concentration and modest capacity usage, this IPO may serve best as part of a diversified portfolio especially if you’re aiming to benefit from a growth story rather than quick listing gains.

If the grey market premium of Shringar House of Mangalsutraand ipo excite you and you’re comfortable with its limitations this IPO might be worth a slice of your allocation.

---

Disclaimer

This article is intended for informational and educational purposes only and should not be considered as investment advice or a recommendation to subscribe to any IPO. Readers are strongly encouraged to conduct their own research, consult with a qualified financial advisor and review the Shringar House of Mangalsutra company’s official Red Herring Prospectus (RHP)  before making any investment decisions. The accuracy of financial figures or valuation estimates is based on publicly available information at the time of writing and may change without notice.

Investing in IPOs involves risk including potential loss of capital. Please invest wisely.

---

All the best to all the learners.

Keep learning , keep growing.